Mitchell Creem - 14 Jun 2023 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Reporting relationship: Director
Issuer ticker: NUTX
Reported as of: 14 Jun 2023
Net transaction value: +$21,415
SEC form: 4
Accepted by SEC: 15 Jun 2023, 14:18:02 UTC
Prior SEC filing: 30 Dec 2022
Next SEC filing: 17 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Mitchell Creem

Key filing fact

Mitchell Creem filed Form 4 for Nutex Health, Inc. (NUTX) on 15 Jun 2023.

Key facts

This page summarizes Mitchell Creem's Form 4 filing for Nutex Health, Inc. (NUTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jun 2023, 14:18.

Change

Previous filing in this sequence was filed on 30 Dec 2022.
Current net transaction value: +$21,415.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUTX transaction

Common Stock

Purchase

Transaction value: $21,415
Shares: +50,000
Change %: +158%
Price: $0.4283
Shares after: 81,746
Date: 14 Jun 2023
Ownership: See note(2)
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.4257 to $0.4301 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

Footnote F2

Mitchell Creem, a Director of the registrant is a co-trustee of the Creem Family Trust, the direct owner of 81,746 of the securities of the registrant reported herein.